IL135302D0 - Bicyclic kinase inhibitors - Google Patents

Bicyclic kinase inhibitors

Info

Publication number
IL135302D0
IL135302D0 IL13530298A IL13530298A IL135302D0 IL 135302 D0 IL135302 D0 IL 135302D0 IL 13530298 A IL13530298 A IL 13530298A IL 13530298 A IL13530298 A IL 13530298A IL 135302 D0 IL135302 D0 IL 135302D0
Authority
IL
Israel
Prior art keywords
kinase inhibitors
bicyclic kinase
bicyclic
inhibitors
Prior art date
Application number
IL13530298A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US6254897P priority Critical
Priority to US7551598P priority
Priority to US9691698P priority
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to PCT/EP1998/006472 priority patent/WO1999020624A1/en
Publication of IL135302D0 publication Critical patent/IL135302D0/en

Links

IL13530298A 1997-10-20 1998-10-13 Bicyclic kinase inhibitors IL135302D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US6254897P true 1997-10-20 1997-10-20
US7551598P true 1998-02-20 1998-02-20
US9691698P true 1998-08-18 1998-08-18
PCT/EP1998/006472 WO1999020624A1 (en) 1997-10-20 1998-10-13 Bicyclic kinase inhibitors

Publications (1)

Publication Number Publication Date
IL135302D0 true IL135302D0 (en) 2001-05-20

Family

ID=27370326

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13530298A IL135302D0 (en) 1997-10-20 1998-10-13 Bicyclic kinase inhibitors

Country Status (26)

Country Link
US (4) US6316464B1 (en)
EP (1) EP1025102B1 (en)
JP (1) JP3579350B2 (en)
KR (1) KR100378937B1 (en)
CN (1) CN1279682A (en)
AT (1) AT267200T (en)
AU (1) AU745579B2 (en)
BR (1) BR9812944A (en)
CA (1) CA2306870A1 (en)
CO (1) CO4980857A1 (en)
DE (1) DE69824029T2 (en)
ES (1) ES2221213T3 (en)
HR (1) HRP20000209A2 (en)
HU (1) HU0100348A3 (en)
ID (1) ID27124A (en)
IL (1) IL135302D0 (en)
MA (1) MA26555A1 (en)
NO (1) NO316734B1 (en)
NZ (1) NZ503685A (en)
PE (1) PE120999A1 (en)
PL (1) PL340412A1 (en)
RU (1) RU2219178C2 (en)
TR (1) TR200001079T2 (en)
TW (1) TWI224596B (en)
WO (1) WO1999020624A1 (en)
YU (1) YU22000A (en)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000057137A (en) * 1996-11-19 2000-09-15 스티븐 엠. 오드레 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
US7605149B1 (en) * 1998-07-13 2009-10-20 University Of South Florida Modulation of the phospholipase A2 pathway as a therapeutic
WO2000019824A1 (en) 1998-10-07 2000-04-13 Smithkline Beecham Corporation Novel treatment for stroke management
WO2000039102A1 (en) * 1998-12-23 2000-07-06 Du Pont Pharmaceuticals Company THROMBIN OR FACTOR Xa INHIBITORS
CZ20021743A3 (en) * 1999-10-21 2002-08-14 F. Hoffmann-La Roche Ag Bicyclic nitrogen heterocycles substituted with alkylamino group functioning together with the group as P38 protein kinase inhibitors
CZ20021744A3 (en) * 1999-10-21 2002-08-14 F. Hoffmann-La Roche Ag Bicyclic nitrogen heterocycles substituted with heteroalkylamino group functioning as P38 protein kinase inhibitors
DE60024480T2 (en) * 1999-10-27 2006-07-27 Novartis Ag Thiazole and imidazo [4,5-b] pyridine compounds and their use as pharmaceuticals
CA2395593C (en) * 1999-12-24 2011-08-02 Aventis Pharma Limited Azaindoles
GB9930698D0 (en) * 1999-12-24 2000-02-16 Rhone Poulenc Rorer Ltd Chemical compounds
US20090306182A1 (en) * 2002-02-20 2009-12-10 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF MAP KINASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
GB0112348D0 (en) * 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
AU2003209119A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
RU2301233C2 (en) * 2002-03-07 2007-06-20 Ф.Хоффманн-Ля Рош Аг Bicyclic pyridines and pyrimidines as kinase p38 inhibitors
EP1490364B1 (en) 2002-03-28 2007-09-26 Eisai R&D Management Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
JP4414881B2 (en) 2002-05-31 2010-02-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 Pyrazole compounds and pharmaceutical compositions comprising this
SG135051A1 (en) * 2002-06-20 2007-09-28 Aventis Pharma Ltd Azaindoles
CN100432073C (en) * 2002-08-06 2008-11-12 霍夫曼-拉罗奇有限公司 6-alkoxy-pyrido-pyrimidines as p-38 MAP kinase inhibitors
EP1388541A1 (en) * 2002-08-09 2004-02-11 Centre National De La Recherche Scientifique Pyrrolopyrazines as kinase inhibitors
JP2006510654A (en) * 2002-12-06 2006-03-30 サイオス・インコーポレーテツド A method of treating diabetes
EP1594459B1 (en) 2002-12-30 2010-02-17 Angiotech International Ag Drug delivery from rapid gelling polymer composition
MXPA05009459A (en) * 2003-03-03 2006-05-17 Array Biopharma Inc P38 inhibitors and methods of use thereof.
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
US7432375B2 (en) 2003-03-06 2008-10-07 Eisai R & D Management Co., Ltd. JNK inhibitors
WO2005000197A2 (en) * 2003-04-11 2005-01-06 The Regents Of The University Of California Selective serine/threonine kinase inhibitors
AU2004233827B2 (en) * 2003-04-24 2009-05-28 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
US7902192B2 (en) 2003-05-15 2011-03-08 Arqule, Inc. Inhibitors of P38 and methods of using the same
EP1628975A2 (en) 2003-05-16 2006-03-01 Eisai Co., Ltd. Jnk inhibitors
EP1631145A4 (en) * 2003-06-06 2009-12-23 Univ Pennsylvania P38 kinase inhibitor compositions and methods of using the same
SE0301906D0 (en) * 2003-06-26 2003-06-26 Astrazeneca Ab New compounds
US7202363B2 (en) * 2003-07-24 2007-04-10 Abbott Laboratories Thienopyridine and furopyridine kinase inhibitors
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
EP2772140B1 (en) * 2003-11-25 2017-04-05 Virginia Tech Intellectual Properties, Inc. Composition for reducing MAP kinase activity in an animal
US7504403B2 (en) * 2004-01-22 2009-03-17 Amgen Inc. Substituted heterocyclic compounds and methods of use
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
US20080044439A1 (en) * 2004-03-11 2008-02-21 David Nathaniel E Compositions and Methods for Preventing and Treating Skin and Hair Conditions
US20050203111A1 (en) * 2004-03-12 2005-09-15 Vvii Newco 2003, Inc. Compositions and methods for preventing and treating skin and hair conditions
US7829560B2 (en) 2004-07-08 2010-11-09 Arqule, Inc. 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
WO2006020365A2 (en) * 2004-07-26 2006-02-23 The Regents Of The University Of California Method for prevention or treatment of inflamatory disease
BRPI0514094A (en) * 2004-08-02 2008-05-27 Osi Pharm Inc compound, composition, and method of treatment of hyperproliferative disorder
CA2584368A1 (en) 2004-10-19 2006-04-27 Arqule, Inc. Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
WO2006056863A1 (en) * 2004-11-23 2006-06-01 Ranbaxy Laboratories Limited Pyrido’2, 3-d!pyrimidines as anti-inflammatory agents
US20090036472A1 (en) * 2005-02-02 2009-02-05 Palle Venkata P Azabicyclo derivatives as anti-inflammatory agents
KR101142363B1 (en) * 2005-06-27 2012-05-21 주식회사유한양행 A composition for treating a cancer comprising pyrrolopyridine derivatives
GB0516156D0 (en) * 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
WO2007031098A1 (en) 2005-09-12 2007-03-22 Xigen S.A. Cell-permeable peptide inhibitors of the jnk signal transduction pathway
AT542800T (en) * 2006-01-31 2012-02-15 Array Biopharma Inc Kinase inhibitors and their application procedure
CN101848909A (en) * 2006-02-14 2010-09-29 沃泰克斯药物股份有限公司 Pyrrolo(3,2-C) pyridines useful as inhibitors of protein kinases
CL2007002617A1 (en) 2006-09-11 2008-05-16 Sanofi Aventis derivatives pyrrolo [2,3-b] pyrazin-6-yl; pharmaceutical composition comprising said compounds; and their use in treating joint inflammation, rheumatoid arthritis, tumors, lymphoma Mantle cell.
US7687893B2 (en) 2006-12-27 2010-03-30 Amkor Technology, Inc. Semiconductor package having leadframe with exposed anchor pads
EP2131858A4 (en) * 2007-03-20 2011-11-23 Cadila Pharmaceuticals Ltd P38 inhibitors
GB0708141D0 (en) 2007-04-26 2007-06-06 Syngenta Participations Ag Improvements in or relating to organic compounds
WO2009143865A1 (en) 2008-05-30 2009-12-03 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
WO2009143864A1 (en) 2008-05-30 2009-12-03 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
JP5767965B2 (en) * 2008-06-10 2015-08-26 プレキシコン インコーポレーテッドPlexxikon Inc. Modulating kinase 5h- pyrrolo [2,3-b] pyrazine derivatives, and their indications
WO2010046215A2 (en) * 2008-10-21 2010-04-29 Syngenta Participations Ag Diaza-indole derivatives and their use as fungicides
DE102008052943A1 (en) 2008-10-23 2010-04-29 Merck Patent Gmbh azaindole derivatives
BRPI0921392A2 (en) 2008-12-05 2016-04-26 Abbott Lab kinase inhibitors with improved safety profile cyp
EP2373784B1 (en) 2008-12-17 2017-10-25 The Scripps Research Institute Generation and maintenance of stem cells
WO2010072228A1 (en) 2008-12-22 2010-07-01 Xigen S.A. Novel transporter constructs and transporter cargo conjugate molecules
EP2245936A1 (en) * 2009-04-27 2010-11-03 Bayer CropScience AG Use of 4-aza indole derivatives for the reduction of mycotoxin contamination
EP2338890A1 (en) 2009-12-22 2011-06-29 Bayer CropScience AG 4,7-Diazaindole derivatives and their use as fungicides
CA2794861A1 (en) * 2010-04-16 2011-10-20 Abbvie Inc. Pyrrolopyrazinone inhibitors of kinases
WO2011160653A1 (en) 2010-06-21 2011-12-29 Xigen S.A. Novel jnk inhibitor molecules
AU2010362444B2 (en) 2010-10-14 2015-08-06 Xigen Inflammation Ltd. Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
WO2013012909A1 (en) 2011-07-20 2013-01-24 Abbott Laboratories Kinase inhibitor with improved aqueous solubility
WO2013033657A2 (en) 2011-09-02 2013-03-07 The Trustees Of Columbia University In The City Of New York CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY
JP6194517B2 (en) 2012-04-27 2017-09-13 学校法人慶應義塾 Neuronal differentiation promoting agent
GB201304526D0 (en) * 2013-03-13 2013-04-24 Proximagen Ltd New compounds
US20140303121A1 (en) * 2013-03-15 2014-10-09 Plexxikon Inc. Heterocyclic compounds and uses thereof
ES2688575T3 (en) 2013-03-15 2018-11-05 Plexxikon Inc Heterocyclic compounds and their uses
JP2016523274A (en) * 2013-06-26 2016-08-08 ザイジェン インフラメーション リミテッド Use of novel cell-permeable peptide inhibitors of jnk signaling pathway for the treatment of various diseases
US10106818B2 (en) 2013-08-16 2018-10-23 The J. David Gladstone Institutes Dual-color HIV reporter system for the detection of latently-infected cells
WO2015173788A1 (en) 2014-05-16 2015-11-19 Westfaelische Wilhelms-Universitaet Muenster Novel anti-infective strategy against influenza virus and s. aureus coinfections
TW201630907A (en) 2014-12-22 2016-09-01 Squibb Bristol Myers Co TGF[beta]R antagonists
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU371228A1 (en) 1971-04-02 1973-02-22 Всесоюзный научно исследовательский химико фармацевтический институт Серго Орджоникидзе Method of obtaining pyrrolo-
RO62428A (en) 1971-05-04 1978-01-15 Thomae Gmbh Dr K Process for the preparation of thyeno- (3,2-d) -pyrimidines
JPH0228593B2 (en) 1980-01-25 1990-06-25 Daiichi Seiyaku Co 22harogenoo3 * 44jihidoroshukugopirimijinruikagobutsutosonoseiho
US4767766A (en) * 1987-01-30 1988-08-30 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo(B)thiophene useful as 5-lipoxygenase inhibitors
EP0300688A1 (en) 1987-07-21 1989-01-25 FISONS plc Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
US5236925A (en) 1991-10-24 1993-08-17 American Home Products Corporation Fused pyrimidines as angiotensin II antagonists
FR2687402B1 (en) 1992-02-14 1995-06-30 Lipha New azaindoles, preparation processes and medicines containing them.
US5502187A (en) 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
DE4304650A1 (en) 1993-02-16 1994-08-18 Thomae Gmbh Dr K Drugs fused 5-membered heterocycles, processes for their preparation and these compounds
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists
US5468757A (en) 1994-01-31 1995-11-21 Eli Lilly And Company 6-azaindole thromboxane synthase inhibitors
US5834469A (en) 1994-06-09 1998-11-10 Smithkline Beecham Corporation Endothelin receptor antagonists
JPH10510510A (en) 1994-06-09 1998-10-13 スミスクライン・ビーチャム・コーポレイション Endothelin receptor antagonists
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5589482A (en) 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
GB2298199A (en) 1995-02-21 1996-08-28 Merck Sharp & Dohme Synthesis of azaindoles
FR2732969B1 (en) 1995-04-14 1997-05-16 Adir New compounds pyridine their process for the preparation and pharmaceutical compositions containing them
JPH11510511A (en) * 1995-08-10 1999-09-14 メルク エンド カンパニー インコーポレーテッド 2,5-substituted aryl pyrroles, compositions and methods of use comprising the compounds
WO1997049706A1 (en) 1996-06-25 1997-12-31 Novartis Ag SUBSTITUTED 7-AMINO-PYRROLO[3,2-d]PYRIMIDINES AND THE USE THEREOF
KR20000057137A (en) * 1996-11-19 2000-09-15 스티븐 엠. 오드레 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
AU7132998A (en) 1997-04-24 1998-11-13 Ortho-Mcneil Corporation, Inc. Substituted pyrrolopyridines useful in the treatment of inflammatory diseases

Also Published As

Publication number Publication date
JP3579350B2 (en) 2004-10-20
RU2219178C2 (en) 2003-12-20
US20030139462A1 (en) 2003-07-24
PE120999A1 (en) 1999-12-01
HRP20000209A2 (en) 2001-04-30
PL340412A1 (en) 2001-01-29
CN1279682A (en) 2001-01-10
AU9749998A (en) 1999-05-10
US6630485B2 (en) 2003-10-07
CO4980857A1 (en) 2000-11-27
ID27124A (en) 2001-03-01
JP2001520227A (en) 2001-10-30
TWI224596B (en) 2004-12-01
ES2221213T3 (en) 2004-12-16
TR200001079T2 (en) 2000-07-21
DE69824029D1 (en) 2004-06-24
NZ503685A (en) 2002-05-31
NO316734B1 (en) 2004-04-19
EP1025102B1 (en) 2004-05-19
CA2306870A1 (en) 1999-04-29
HU0100348A3 (en) 2002-12-28
WO1999020624A1 (en) 1999-04-29
EP1025102A1 (en) 2000-08-09
DE69824029T2 (en) 2005-05-12
MA26555A1 (en) 2004-12-20
NO20001940L (en) 2000-04-13
KR100378937B1 (en) 2003-05-09
US6316464B1 (en) 2001-11-13
US20020013354A1 (en) 2002-01-31
US6479507B2 (en) 2002-11-12
BR9812944A (en) 2000-08-08
AT267200T (en) 2004-06-15
US20010044538A1 (en) 2001-11-22
YU22000A (en) 2003-01-31
HU0100348A2 (en) 2001-08-28
NO20001940D0 (en) 2000-04-13
AU745579B2 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
DE69826273D1 (en) Knochentransplantat-composite und -spacern
DE69817801D1 (en) Arylsulfonylhydroxamsäurederivate
DE69826254D1 (en) Modulare humerusprothese
DE69821950D1 (en) N-aroylphenylalaninderivate
DE69837675D1 (en) Pyrazolderivate
DE69709184D1 (en) Knöchel-fuss orthese
DE69804946D1 (en) Opthalmische formmasse
DE69831868D1 (en) Antithrombosemittel
DE69808438D1 (en) Hüftprothese
DE69736807D1 (en) Lipid kinase
EG21556A (en) Bicyclic amine derivatives
DE69809754D1 (en) Substituierte 6-phenylphenanthridine
DE69816992D1 (en) Benzimidazolderivate
DE69829667D1 (en) Hydrocyanierungsverfahren
GB2346877B (en) 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DE69827940D1 (en) Thiarylsulfonamid-hydroxamsäurederivate
DE69837702D1 (en) Lastsensor
DE69835201D1 (en) Neoglycoproteine
EG23871A (en) Protein kinase c inhibitor
DE69813225D1 (en) Blockcopolymere
DE69837398D1 (en) Festphasenextrationsplatte
DE69840963D1 (en) Thermale therapievorrichtung
DE69838100D1 (en) Gefässprothese
DE59804066D1 (en) Triazolinthion-phosphorsäure-derivate
DE69830051D1 (en) Endotrachealtubus